期刊文献+

长春西汀自微乳化释药系统的体外释药特性研究 被引量:6

Release Characters of Vinpocetine Self-Microemulsifying Drug Delivery System in Vitro
暂未订购
导出
摘要 目的:研究长春西汀自微乳化释药系统(VIN-SMEDDS)的体外释药特性。方法:进行了体外释放度实验,考察释放度实验方法学、释放介质、转速和制剂因素对药物释放特性的影响。结果:释放度实验方法学、释放介质、转速和制剂处方因素都会对药物释放测定结果造成影响。采用反相透析技术能较好地模拟口服后的体内生理情况,在人工肠液中,转速50r·min^(-1)下,VIN-SMEDDS 累积释放百分率3h 达到68.45%。SMEDDS 制剂的电性对释放基本无影响,VIN-SMEDDS 的体外释放比长春西汀自乳化释药系统(VIN-SEDDS)好。结论:长春西汀自乳化释药系统显著提高了药物的释放速度和程度。体外反相透析释放实验的透膜限速过程属于被动扩散过程。 Objective: To study the release characters of Vinpocetine self- microemulsifying drug delivery system (VIN-SMEDDS) in vitro. Method: The dissolution of VIN-SMEDDS were determined in vitro. And the effects of different dissolution methods, dissolution media, rotational speeds and preparations on release characters of drug were studied. Result: The release characters of drug were influenced by different dissolution methods, media, rotational speeds and preparations in vitro. The reverse dialysis bag technique could preferably simulate the situation of oral drug. The cumulative dissolution ratio of VIN-SMEDDS at 3 h in pH 6.8 PBS under 50 r · min^- 1reached 68.45%. And the potention of SMEDDS almost had no effects on the dissolution tests. The cumulative dissolution ratio of VIN from SMEDDS was higher than that from SMEDDS. Conclusion: The formulation of VIN-SMEDDS can significantly improve the dissolution of vinpocetine. The process of the drug penetrating membrane with reverse dialysis technique fits passive diffusion.
出处 《中国药师》 CAS 2006年第12期1092-1095,共4页 China Pharmacist
关键词 长春西汀 自微乳化释药系统 体外释放度 Vinpocetine Self-microemulsifying drug delivery system Dissolution in vitro
  • 相关文献

参考文献6

  • 1Hauss DJ,Fogal SE,Ficorilli JV,et al.Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly wAter-soluble LTB4 inhibitor[J].J Pharm Sci,1998,87 (2):164-169
  • 2Bereczki D,Fekete I.A systematic review of vinpocenne therapy in acute ischaemic stroke[J].Eur J Clin Pharmacol,1999,55:349-352
  • 3Miskolczi P,Korma K,Polgar M,et al.Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans[J].Eur J Drug Metab Pharmacokinet,1990,15:1-5
  • 4Ashington C.Drug release from microdisperse systems:a critical review[J].Int J Pharm,1990,58(1):1-12
  • 5Pudleiner P,Vereczkey L.Study on the absorption of vinpocetine and apovincaminic acid[J].Eur J Drug Metab Pharmacokinet,1993,18(4):317 -321
  • 6潘卫三,李华,李嘉煜,姜晓薇.长春西汀体外经皮渗透性实验中接受液的选择[J].沈阳药科大学学报,2002,19(4):239-243. 被引量:11

二级参考文献7

  • 1王祥.高效液相色谱法测定长春西汀(片)的含量及其有关物质的研究[J].药物分析杂志,1995,15(4):23-26. 被引量:15
  • 2David Rolf.Chemical and physical methods of enchancing transdermal drug delivery [J].Pharmaceutical Technology ,1988,9:130-140.
  • 3Kenneth AW.Percutaneous absorption and transdermal therapy [J].Pharmaceutical Technology ,1986,3:30-46.
  • 4YW Chien,KH Valia.Development of a dynamic skin permeation system for long term permeation studies [J].Drug Dev Ind Pharm,1984,10:574-599.
  • 5JL Zata.Fundamental of transdermal controlled drug adminstration:phsicochemical consideration [J].Drug Dev Ind Pharm,1983,9:561-577.
  • 6梁文权.经皮给药制剂 [M].北京:中国医药科技出版社,1992.151-152.
  • 7徐群为,周学敏,郝钦,许小凤.皮肤经促进剂预处理对双氯芬酸钾渗透的影响[J].中国医药工业杂志,1998,29(2):68-70. 被引量:14

共引文献10

同被引文献51

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部